Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Agranulocytosis

fluorodeoxyglucose f18 has been researched along with Agranulocytosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbet, N; Buuren, IV; Capdeville, R; Choi, L; de Vries, EG; Dumez, H; Groen, HJ; Muskiet, F; Oosterom, AT; Paridaens, R; Seeghers, M; Uges, DR; van der Graaf, WT	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Agranulocytosis

Article	Year
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours. British journal of cancer, 2000, Volume: 83, Issue:5 Topics: Adenosylmethionine Decarboxylase; Adult; Aged; Agranulocytosis; Amidines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Indans; Male; Middle Aged; Neoplasms; Polyamines; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed	2000

Article

Year

A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours.

British journal of cancer, 2000, Volume: 83, Issue:5

Topics: Adenosylmethionine Decarboxylase; Adult; Aged; Agranulocytosis; Amidines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Indans; Male; Middle Aged; Neoplasms; Polyamines; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed

2000